From 1 April 2018 General Practitioners and nurse practitioners are able to prescribe pre-exposure prophylaxis (PrEP) against human immunodeficiency virus (HIV) infection under Section 85 of the Pharmaceutical Benefits Scheme (PBS). The prescription will be able to be dispensed from any pharmacy, however some pharmacies may need to order the medication which may take a few days.

A STREAMLINED authority is required and the clinical and population criteria are:

  • The treatment must be for patients at medium to high risk of HIV infection, as defined by the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM) HIV pre-exposure prophylaxis: clinical guidelines (2017).
  • The patient must have a negative HIV test result prior to treatment with PBS-subsidised PrEP therapy.
  • The patient must be 18 years or older.

There are a number of resources available to support prescribing of PrEP:

Click here to learn more about PrEP medication on the Schedule of Pharmaceutical Benefits.